Skip to main content
Deciphera
Deciphera Medical Affairs
  • Our Company
    • Who We Are
    • Leadership
  • Focus Areas
    • Overview
    • Oncology
    • Immunology & Inflammation
    • Neurology
  • Pipeline
    • Ongoing Clinical Trials
    • Presentations & Publications
  • Patients & Care Partners
    • Expanded Access
  • Healthcare Professionals (Coming soon!)
  • Our Medicines
  • Join Us
    • Our Culture
    • Open Positions
  • News
  • Ono Pharma

ASCPT

March 04, 2026
Vimseltinib
ASCPT

Exposure-Response Analyses for Vimseltinib in Patients With Tenosynovial Giant Cell Tumor

March 05, 2026
Vimseltinib
ASCPT

Population Pharmacokinetic Analyses of Vimseltinib in Healthy Volunteers and Patients With Solid Tumors or Tenosynovial Giant Cell Tumor

© 2026 Deciphera Pharmaceuticals, LLC. Deciphera Pharmaceuticals, LLC, DECIPHERA, and the Deciphera logo are registered trademarks of Deciphera Pharmaceuticals.

  • Privacy Policy
  • Contact Us
  • Terms of Use
linkedin twitter
DCPH-M01057 v1 09/26
Back to top